Page last updated: 2024-09-04

torcetrapib and Urinary Tract Diseases

torcetrapib has been researched along with Urinary Tract Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Merrick, GS; Moyad, MA	1

Other Studies

1 other study(ies) available for torcetrapib and Urinary Tract Diseases

Article	Year
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapib. Urologic nursing, 2007, Volume: 27, Issue:2 Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Clinical Trials, Phase III as Topic; Drug Industry; Exercise Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Patient Education as Topic; Quinolines; Risk Reduction Behavior; Smoking Cessation; Stress, Psychological; United States; Urologic Diseases; Weight Loss	2007

Article

Year

Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapib.

Urologic nursing, 2007, Volume: 27, Issue:2

Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Clinical Trials, Phase III as Topic; Drug Industry; Exercise Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Patient Education as Topic; Quinolines; Risk Reduction Behavior; Smoking Cessation; Stress, Psychological; United States; Urologic Diseases; Weight Loss

2007